Ninety-one patients with adenocarcinoma of the cervix had 4 tumour markers (TMs) assayed
before treatment. Serum squamous cell carcinoma antigen (SCC)(n= 91) was raised in 25%; …

The prognostic value of the pretreatment serum CA 125, squamous cell carcinoma antigen
(SCC), and carcinoembryonic antigen (CEA) levels in relation to tumor type, vascular …

Purpose The purpose was to evaluate the prognostic significance of serum tumour markers
and other potential prognostic factors in cervical cancer. Materials and methods Five …

A study was made of the prognostic value of measurements of pretreatment serum marker
levels in patients with carcinoma of the uterine cervix undergoing radiotherapy. The markers …

A review is given of the clinical use and interpretation of serum tumor marker levels during
the treatment of patients with cancer of the uterine cervix. Pretreatment serum squamous cell …

Three hundred two patients with squamous cell carcinoma of the cervix had pretreatment
measurement of serum levels of tissue polypeptide antigen (TPA) and squamous cell …

The clinical value of SCC levels has been evaluated in four groups of women affected by
cervical carcinoma. Among the 116 newly diagnosed patients, the SCC pretreatment level …

Serum squamous cell carcinoma antigen (SCCa) concentrations were determined by a
radioimmunoassay kit before and during the treatment of 50 patients with cervical …

SUMMARY Between 1978 and 1987, 439 patients with primary cervical carcinoma were
admitted to our department. Seventy-seven patients (17.5%) had cervical adenocarcinoma …

Pretreatment levels of carcinoembryonic antigen (CEA) correlate well with the extent of
disease in squamous cell and adenocarcinoma of the cervix. These two tumor types …